Fibrosis-Related Biomarkers and Incident Cardiovascular Disease in Older Adults: The Cardiovascular Health Study
View/ Open
Author
Agarwal, Isha
Glazer, Nicole
Barasch, Eddy
Biggs, Mary
Djousse, Luc
Fitzpatrick, Annette
Gottdiener, John
Ix, Joachim
Kizer, Jorge
Rimm, Eric Bruce::0ab2926c8242f35e5a982e3cf59f4987::600
Sicovick, David
Tracy, Russell
Mukamal, Kenneth
Published Version
https://doi.org/10.1161/CIRCEP.114.001610Metadata
Show full item recordCitation
Agarwal, Isha, Nicole L. Glazer, Eddy Barasch, Mary L. Biggs, Luc Djousse, Annette L. Fitzpatrick, John S. Gottdiener, et al. 2014. “Fibrosis-Related Biomarkers and Incident Cardiovascular Disease in Older Adults.” Circulation: Arrhythmia and Electrophysiology 7 (4): 583–89. https://doi.org/10.1161/circep.114.001610.Abstract
Background-Fibrotic changes in the heart and arteries have been implicated in a diverse range of cardiovascular diseases (CVD), but whether circulating biomarkers that reflect fibrosis are associated with CVD is unknown.Methods and Results-We determined the associations of 2 biomarkers of fibrosis, transforming growth factor-beta (TGF-beta), and procollagen type III N-terminal propeptide (PIIINP), with incident heart failure, myocardial infarction, and stroke among community-living older adults in the Cardiovascular Health Study. We measured circulating TGF-beta (n=1371) and PIIINP (n=2568) from plasma samples collected in 1996 and ascertained events through 2010. Given TGF-beta's pleiotropic effects on inflammation and fibrogenesis, we investigated potential effect modification by C-reactive protein in secondary analyses. After adjustment for sociodemographic, clinical, and biochemical risk factors, PIIINP was associated with total CVD (hazard ratio [HR] per SD=1.07; 95% confidence interval [CI], 1.01-1.14) and heart failure (HR per SD=1.08; CI, 1.01-1.16) but not myocardial infarction or stroke. TGF-beta was not associated with any CVD outcomes in the full cohort but was associated with total CVD (HR per SD=1.16; CI, 1.02-1.31), heart failure (HR per SD=1.16; CI, 1.01-1.34), and stroke (HR per SD=1.20; CI, 1.01-1.42) among individuals with C-reactive protein above the median, 2.3 mg/L (P interaction <0.05).Conclusions-Our findings provide large-scale, prospective evidence that circulating biomarkers of fibrosis, measured in community-living individuals late in life, are associated with CVD. Further research on whether TGF-beta has a stronger fibrogenic effect in the setting of inflammation is warranted.Terms of Use
This article is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#OAPCitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41245538
Collections
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)